HIGHLIGHTS
- who: Cornelia Speth and collaborators from the Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria have published the Article: Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment, in the Journal: (JOURNAL)
- what: Drug resistance is of particular relevance for PDAC since this is one of the major reasons for high mortality. More specifically, the model proposed by this study group implies the recognition of Malassezia ssp. by MBL and the activation of the lectin pathway of the complement with consequent production of C3. In the study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.